𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Stereoselective hydrolysis of ICRF-187 (dexrazoxane) and ICRF-186 by dihydropyrimidine amidohydrolase

✍ Scribed by Dr. Brian B. Hasinoff

Book ID
102077650
Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
332 KB
Volume
6
Category
Article
ISSN
0899-0042

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Stereoselective metabolism of dexrazoxan
Stereoselective metabolism of dexrazoxane (ICRF-187) and levrazoxane (ICRF-186)
✍ Brian B. Hasinoff; Ronald G. Aoyama πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 1 views

A chiral HPLC method has been developed to separate razoxane (ICRF-159) in blood plasma into its enantiomers dexrazoxane (ICRF-187) and levrazoxane (ICRF-186). Dexrazoxane is clinically used as a doxorubicin cardioprotective agent and little is known of its in vivo metabolism. After intravenous admi

Characterisation of cytotoxicity and DNA
Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells
✍ Lars H Jensen; Marielle Dejligbjerg; Lasse T Hansen; Morten Grauslund; Peter B J πŸ“‚ Article πŸ“… 2004 πŸ› BioMed Central 🌐 English βš– 748 KB

## Background Bisdioxopiperazine anti-cancer agents are inhibitors of eukaryotic DNA topoisomerase II, sequestering this protein as a non-covalent protein clamp on DNA. It has been suggested that such complexes on DNA represents a novel form of DNA damage to cells. In this report, we characterise t